1206102-11-5
1206102-11-5 (4R,12As)-N-(2,4-二氟苄基)-7-苯氧基-4-甲基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]噁嗪烷-9-甲酰胺
1206102-11-5海关数据
别名: (4R,12As)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-4-甲基-6,8-二氧代-7-(苯基甲氧基)-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-甲酰胺; (4R,12As)-N-(2,4-二氟苄基)-7-苯氧基-4-甲基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷-9-甲酰胺; 度鲁特韦中间体2; 德罗特韦 Bn-N-1
英文名: (4R,12As)-N-(2,4-Difluorobenzyl)-7-Benzylhydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12A-Hexahydro-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-Carboxamide ; (4R,12As)-N-[(2,4-Difluorophenyl)Methyl]-3,4,6,8,12,12A-Hexahydro-4-Methyl-6,8-Dioxo-7-(Phenylmethoxy)-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-Carboxamide
分子式: C27H25F2N3O5 | 分子量: 509.5000

1206102-11-5供应信息

供应商 纯度 点赞 查看
上海升华医药科技有限公司 CPHI2026 查看详情